Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
- PMID: 31727428
- DOI: 10.1016/j.ophtha.2019.10.002
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
Abstract
Purpose: To report 3-year results of the Primary Tube Versus Trabeculectomy (PTVT) Study.
Design: Unmasked multicenter randomized clinical trial.
Participants: Two hundred forty-two eyes of 242 patients with medically uncontrolled glaucoma and no previous incisional ocular surgery, including 125 in the tube group and 117 in the trabeculectomy group.
Methods: Patients were enrolled at 16 clinical centers and were assigned randomly to treatment with a tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC; 0.4 mg/ml for 2 minutes).
Main outcome measures: The primary outcome measure was the rate of surgical failure, defined as intraocular pressure (IOP) of more than 21 mmHg or reduced less than 20% from baseline, IOP of 5 mmHg or less, reoperation for glaucoma, or loss of light perception vision. Secondary outcome measures included IOP, glaucoma medical therapy, visual acuity, and surgical complications.
Results: The cumulative probability of failure after 3 years of follow-up was 33% in the tube group and 28% in the trabeculectomy group (P = 0.17; hazard ratio, 1.39; 95% confidence interval, 0.9-2.2). Mean ± standard deviation IOP was 14.0±4.2 mmHg in the tube group and 12.1±4.8 mmHg in the trabeculectomy group at 3 years (P = 0.008), and the number of glaucoma medications was 2.1±1.4 in the tube group and 1.2±1.5 in the trabeculectomy group (P < 0.001). Serious complications requiring reoperation or producing loss of 2 or more Snellen lines developed in 3 patients (2%) in the tube group and 9 patients (8%) in the trabeculectomy group (P = 0.11).
Conclusions: There was no significant difference in the rate of surgical failure between the 2 surgical procedures at 3 years. Trabeculectomy with MMC achieved lower IOP with use of fewer glaucoma medications compared with tube shunt surgery after 3 years of follow-up in the PTVT Study. Serious complications producing vision loss or requiring reoperation occurred with similar frequency after both surgical procedures.
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Jul;127(7):e44-e45. doi: 10.1016/j.ophtha.2020.02.030. Ophthalmology. 2020. PMID: 32564820 No abstract available.
-
Reply.Ophthalmology. 2020 Jul;127(7):e45-e46. doi: 10.1016/j.ophtha.2020.02.033. Ophthalmology. 2020. PMID: 32564821 No abstract available.
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Sep;127(9):e79. doi: 10.1016/j.ophtha.2020.04.013. Ophthalmology. 2020. PMID: 32828202 No abstract available.
-
Reply.Ophthalmology. 2020 Sep;127(9):e79-e80. doi: 10.1016/j.ophtha.2020.04.014. Ophthalmology. 2020. PMID: 32828203 No abstract available.
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Sep;127(9):e80-e81. doi: 10.1016/j.ophtha.2020.04.024. Ophthalmology. 2020. PMID: 32828204 No abstract available.
-
Reply.Ophthalmology. 2020 Sep;127(9):e81-e82. doi: 10.1016/j.ophtha.2020.04.025. Ophthalmology. 2020. PMID: 32828205 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical